Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Performance Enhancing Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Performance Enhancing Drugsmarket, defines the market attractiveness level of Performance Enhancing Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Performance Enhancing Drugs industry, describes the types of Performance Enhancing Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Performance Enhancing Drugs market and the development prospects and opportunities of Performance Enhancing Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Performance Enhancing Drugs market in Chapter 13.
By Player:
Douglas Laboratories
Eli Lilly And Company
Bayer
Balkan Pharmaceuticals
BrainAlert
Novo Nordisk
Taj Pharmaceuticals
AstraZeneca
Onnit Labs
By Type:
Ergogenic Aids
Nootropic
By End-User:
Athletes
Body Builders
Students
Militaries
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Performance Enhancing Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Performance Enhancing Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Performance Enhancing Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Performance Enhancing Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Performance Enhancing Drugs Market Analysis and Outlook to 2022
-
7.1 Global Performance Enhancing Drugs Consumption (2017-2022)
-
7.2 United States Performance Enhancing Drugs Consumption (2017-2022)
-
7.3 Europe Performance Enhancing Drugs Consumption (2017-2022)
-
7.4 China Performance Enhancing Drugs Consumption (2017-2022)
-
7.5 Japan Performance Enhancing Drugs Consumption (2017-2022)
-
7.6 India Performance Enhancing Drugs Consumption (2017-2022)
-
7.7 South Korea Performance Enhancing Drugs Consumption (2017-2022)
8 Region and Country-wise Performance Enhancing Drugs Market Analysis and Outlook to 2028
-
8.1 Global Performance Enhancing Drugs Consumption Forecast (2022-2028)
-
8.2 United States Performance Enhancing Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Performance Enhancing Drugs Consumption Forecast (2022-2028)
-
8.4 China Performance Enhancing Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Performance Enhancing Drugs Consumption Forecast (2022-2028)
-
8.6 India Performance Enhancing Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Performance Enhancing Drugs Consumption Forecast (2022-2028)
9 Global Performance Enhancing Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Performance Enhancing Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ergogenic Aids Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Nootropic Consumption and Growth Rate (2017-2022)
-
9.2 Global Performance Enhancing Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Athletes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Body Builders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Students Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Militaries Consumption and Growth Rate (2017-2022)
10 Global Performance Enhancing Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Performance Enhancing Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ergogenic Aids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Nootropic Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Performance Enhancing Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Athletes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Body Builders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Students Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Militaries Consumption Forecast and Growth Rate (2022-2028)
11 Global Performance Enhancing Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Performance Enhancing Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Performance Enhancing Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Performance Enhancing Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Performance Enhancing Drugs Market Competitive Analysis
-
14.1 Douglas Laboratories
-
14.1.1 Douglas Laboratories Company Details
-
14.1.2 Douglas Laboratories Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Douglas Laboratories Performance Enhancing Drugs Product and Service
-
14.2 Eli Lilly And Company
-
14.2.1 Eli Lilly And Company Company Details
-
14.2.2 Eli Lilly And Company Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly And Company Performance Enhancing Drugs Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Performance Enhancing Drugs Product and Service
-
14.4 Balkan Pharmaceuticals
-
14.4.1 Balkan Pharmaceuticals Company Details
-
14.4.2 Balkan Pharmaceuticals Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Balkan Pharmaceuticals Performance Enhancing Drugs Product and Service
-
14.5 BrainAlert
-
14.5.1 BrainAlert Company Details
-
14.5.2 BrainAlert Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BrainAlert Performance Enhancing Drugs Product and Service
-
14.6 Novo Nordisk
-
14.6.1 Novo Nordisk Company Details
-
14.6.2 Novo Nordisk Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novo Nordisk Performance Enhancing Drugs Product and Service
-
14.7 Taj Pharmaceuticals
-
14.7.1 Taj Pharmaceuticals Company Details
-
14.7.2 Taj Pharmaceuticals Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Taj Pharmaceuticals Performance Enhancing Drugs Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Performance Enhancing Drugs Product and Service
-
14.9 Onnit Labs
-
14.9.1 Onnit Labs Company Details
-
14.9.2 Onnit Labs Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Onnit Labs Performance Enhancing Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Performance Enhancing Drugs
-
Figure Performance Enhancing Drugs Picture
-
Table Global Performance Enhancing Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Performance Enhancing Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Performance Enhancing Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Performance Enhancing Drugs Consumption by Country (2017-2022)
-
Figure United States Performance Enhancing Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Performance Enhancing Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Performance Enhancing Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Performance Enhancing Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Performance Enhancing Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Performance Enhancing Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Performance Enhancing Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Performance Enhancing Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Performance Enhancing Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Performance Enhancing Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Performance Enhancing Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Performance Enhancing Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Performance Enhancing Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ergogenic Aids Consumption and Growth Rate (2017-2022)
-
Figure Global Nootropic Consumption and Growth Rate (2017-2022)
-
Figure Global Athletes Consumption and Growth Rate (2017-2022)
-
Figure Global Body Builders Consumption and Growth Rate (2017-2022)
-
Figure Global Students Consumption and Growth Rate (2017-2022)
-
Figure Global Militaries Consumption and Growth Rate (2017-2022)
-
Figure Global Ergogenic Aids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nootropic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Athletes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Body Builders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Students Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Militaries Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Performance Enhancing Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Performance Enhancing Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Douglas Laboratories (Foundation Year, Company Profile and etc.)
-
Table Douglas Laboratories Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Douglas Laboratories Performance Enhancing Drugs Product and Service
-
Table Eli Lilly And Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly And Company Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly And Company Performance Enhancing Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Performance Enhancing Drugs Product and Service
-
Table Balkan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Balkan Pharmaceuticals Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Balkan Pharmaceuticals Performance Enhancing Drugs Product and Service
-
Table BrainAlert (Foundation Year, Company Profile and etc.)
-
Table BrainAlert Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table BrainAlert Performance Enhancing Drugs Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Performance Enhancing Drugs Product and Service
-
Table Taj Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Taj Pharmaceuticals Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taj Pharmaceuticals Performance Enhancing Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Performance Enhancing Drugs Product and Service
-
Table Onnit Labs (Foundation Year, Company Profile and etc.)
-
Table Onnit Labs Performance Enhancing Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Onnit Labs Performance Enhancing Drugs Product and Service
-
